AMED:NGS-Amedisys Inc

EQUITY | Medical Care | Nasdaq Global Select

Last Closing

USD 124.1

Change

+1.10 (+0.89)%

Market Cap

USD 1.35B

Volume

0.39M

Analyst Target

USD 136.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amedisys Inc is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The Company's operations include servicing patients through its segments home health and hospice.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Care

ETFs Containing AMED

OLD 0.00 % 0.50 %

N/A

N/A
RWM ProShares Short Russell20.. 0.00 % 0.95 %

+0.31 (+-0.20%)

USD 0.21B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

+1.33 (+-0.20%)

USD 0.14B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

+0.33 (+-0.20%)

USD 0.06B
TZA Direxion Daily Small Cap .. 0.00 % 0.95 %

+0.87 (+-0.20%)

USD 0.53B
MARB First Trust Vivaldi Merge.. 0.00 % 0.00 %

-0.04 (-0.20%)

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.97% 58% F 43% F
Dividend Return N/A N/A N/A N/A F
Total Return 5.97% 58% F 41% F
Trailing 12 Months  
Capital Gain 32.04% 75% C 90% A-
Dividend Return N/A N/A N/A N/A F
Total Return 32.04% 75% C 89% A-
Trailing 5 Years  
Capital Gain 695.51% 75% C 98% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 695.51% 75% C 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 54.04% 80% B- 89% A-
Dividend Return 54.04% 80% B- 88% B+
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 47.09% 40% F 30% F
Risk Adjusted Return 114.76% 93% A 96% N/A
Market Capitalization 1.35B 100% F 88% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 32.60 64% 30%
Price/Book Ratio 7.64 23% 16%
Price / Cash Flow Ratio 0.00 77% 86%
Price/Free Cash Flow Ratio 0.00 77% 85%
Management Effectiveness  
Return on Equity 23.23% 91% 92%
Return on Invested Capital N/A N/A N/A
Return on Assets 10.08% 100% 94%
Debt to Equity Ratio 1.20% 67% 88%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector